Developmental Core

发展核心

基本信息

  • 批准号:
    10222674
  • 负责人:
  • 金额:
    $ 34.06万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-09-30 至 2025-05-31
  • 项目状态:
    未结题

项目摘要

ABSTRACT – DEVELOPMENTAL CORE The overall goal of the Wadsworth Center’s Human Health Exposure Analysis Resource (WC-HHEAR) Developmental Core (Dev. Core) is to capitalize on the existing resources, expertise, and capacity at Wadsworth to develop and validate novel methods and analytical approaches for quantitative measurements of emerging chemicals in biospecimens, i.e., pushing the boundaries of human biomonitoring. Drs. Kannan and Parsons, the MPIs on this proposal, are leaders in their respective fields with more than 700 combined publications. They have spent the last two decades building the human biomonitoring program at Wadsworth – in Dr. Parsons’ Trace Elements Laboratory (TREL) and in Dr. Kannan’s Human Organics Biomonitoring Lab (HOBL). These efforts include assembling the current analytical capability; discovering emerging chemicals in human tissues and fluids; developing and validating new methods of analysis; and supporting the advancement of human health studies and the environment. Both HOBL and TREL have expansive lists of assays and capabilities that are part of the repertoire committed to support the WC-HHEAR targeted analysis resource (TAR). One of the Dev. Core’s functions will be to improve existing methods, requiring less sample volume for analysis, doing more with a limited amount of sample, improving detection limits, increasing sample throughput, reducing costs, and leveraging state-of-the-art technologies as they become available. For example, the proposed Dev. Core will investigate extractions that can be implemented for use on multiple classes of organic chemicals and improving detectability for trace elements using a new generation of technology based on inorganic tandem mass spectrometry. New capabilities will be developed in the Dev. Core and validated according to the international standards for single-laboratory method validation. The Dev. Core will build on its existing expertise with non-traditional matrices to offer more targets in more matrix types and will respond to HHEAR – driven by either discoveries in the untargeted resource, increased demand from HHEAR clients, or suggestions from the HHEAR program office. The transfer of these improvements to current methods will be facilitated by the WC-HHEAR administrative core, where key staff are integrated into both the TAR and Dev. Core. It is only through the progress outlined above that high-quality, quantitative, exposome research can flourish.
摘要- 沃兹沃斯中心的人类健康暴露分析资源(WC-HHEAR)的总体目标 开发核心(Dev.核心)是利用现有的资源、专业知识和能力, 沃兹沃斯开发和验证新的方法和分析方法的定量 测量生物样本中出现的化学物质,即,挑战人类的极限 生物监测Kannan博士和Parsons博士是该提案的MPI,他们是各自领域的领导者 出版物超过700种。在过去的二十年里, 生物监测计划在沃兹沃斯-在博士帕森斯的微量元素实验室(TREL)和博士。 Kannan的人体有机物生物监测实验室(HOBL)。这些努力包括组装电流 分析能力;发现人体组织和体液中新出现的化学物质;开发和 验证新的分析方法;支持人类健康研究的进步, 环境HOBL和TREL都有广泛的分析和功能列表,这些列表是 致力于支持WC-HHEAR靶向分析资源(TAR)的库。其中一个Dev。 核心的功能将是改善现有的方法,需要更少的样品量进行分析, 有限的样品量,提高检测限,增加样品吞吐量,减少 成本,并利用最先进的技术,因为它们变得可用。例如,拟议的 Dev.核心将调查提取,可以实施用于多种类别的有机 利用新一代技术, 无机串联质谱将在Dev中开发新功能。核心和验证 按照国际标准进行单实验室方法验证。Dev。核心将建立 利用其现有的非传统矩阵专业知识,以提供更多矩阵类型的更多目标,并将 响应HHEAR -由非目标资源的发现, HHEAR客户或HHEAR项目办公室的建议。将这些改进转移到 目前的方法将由WC-HHEAR行政核心提供便利,核心的主要工作人员将被整合 进入TAR和Dev。核心只有通过上述进展, 定量的、麻烦的研究可以蓬勃发展。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kurunthachalam Kannan其他文献

Kurunthachalam Kannan的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kurunthachalam Kannan', 18)}}的其他基金

MEASUREMENT OF ENVRIRONMENTAL CHEMICALS IN THE EAGeR TRIAL
EGeER 试验中环境化学物质的测量
  • 批准号:
    9569856
  • 财政年份:
    2017
  • 资助金额:
    $ 34.06万
  • 项目类别:
ENVIRONMENTAL CHEMICAL ANALYSIS OF HUMAN SPECIMENS FOR DIPHR - PROJECT TRACKING AND CONSULTATION
DIPHR 人体样本的环境化学分析 - 项目跟踪和咨询
  • 批准号:
    9934047
  • 财政年份:
    2016
  • 资助金额:
    $ 34.06万
  • 项目类别:
ENVIRONMENTAL CHEMICAL ANALYSIS OF HUMAN SPECIMENS FOR DIPHR - PROJECT TRACKING AND CONSULTATION
DIPHR 人体样本的环境化学分析 - 项目跟踪和咨询
  • 批准号:
    9517629
  • 财政年份:
    2016
  • 资助金额:
    $ 34.06万
  • 项目类别:
ENVIRONMENTAL CHEMICAL ANALYSIS OF HUMAN BIOSPECIMENS FOR DIPHR
人体生物样本 DIPHR 的环境化学分析
  • 批准号:
    9305299
  • 财政年份:
    2016
  • 资助金额:
    $ 34.06万
  • 项目类别:
ENVIRONMENTAL CHEMICAL ANALYSIS OF HUMAN SPECIMENS FOR DIPHR - PROJECT TRACKING AND CONSULTATION
DIPHR 人体样本的环境化学分析 - 项目跟踪和咨询
  • 批准号:
    9305284
  • 财政年份:
    2016
  • 资助金额:
    $ 34.06万
  • 项目类别:
ENVIROMENTAL PHENOLS AND PHTHALATES IN SEMINAL FLUID: IMPLICATIONS FOR MALE FECUNDITY
精液中的环境酚类和邻苯二甲酸盐:对男性生育力的影响
  • 批准号:
    9149809
  • 财政年份:
    2015
  • 资助金额:
    $ 34.06万
  • 项目类别:
Wadsworth Center's Human Health and Exposure Analysis Resource (WC-HHEAR)
沃兹沃斯中心的人类健康和暴露分析​​资源 (WC-HHEAR)
  • 批准号:
    10434774
  • 财政年份:
    2015
  • 资助金额:
    $ 34.06万
  • 项目类别:
Targeted Analysis
针对性分析
  • 批准号:
    10836245
  • 财政年份:
    2015
  • 资助金额:
    $ 34.06万
  • 项目类别:
Developmental Core
发展核心
  • 批准号:
    10839555
  • 财政年份:
    2015
  • 资助金额:
    $ 34.06万
  • 项目类别:
Wadsworth Center's Human Health and Exposure Analysis Resource (WC-HHEAR)
沃兹沃斯中心的人类健康和暴露分析​​资源 (WC-HHEAR)
  • 批准号:
    10222672
  • 财政年份:
    2015
  • 资助金额:
    $ 34.06万
  • 项目类别:

相似海外基金

Mechanisms of epidermal differentiation by hypoxia response and identification of amniotic fluid-derived factors
缺氧反应引起的表皮分化机制及羊水源性因子的鉴定
  • 批准号:
    23H02136
  • 财政年份:
    2023
  • 资助金额:
    $ 34.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Targeting fetal lung macrophage dysregulation in congenital diaphragmatic hernia with amniotic fluid stem cell extracellular vesicle therapy
羊水干细胞胞外囊泡治疗针对先天性膈疝胎儿肺巨噬细胞失调
  • 批准号:
    479991
  • 财政年份:
    2023
  • 资助金额:
    $ 34.06万
  • 项目类别:
    Operating Grants
Early Treatment With H12-(ADP)-liposomes Ameliorates Post-partum Hemorrhage With Coagulopathy Caused by Amniotic Fluid Embolism in Rabbits.
H12-(ADP)-脂质体的早期治疗可改善兔羊水栓塞引起的产后出血和凝血病。
  • 批准号:
    23K08828
  • 财政年份:
    2023
  • 资助金额:
    $ 34.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Establishment of a novel amniotic fluid biomarker to predict the prognosis of fetal growth restriction
建立一种新型羊水生物标志物来预测胎儿生长受限的预后
  • 批准号:
    23K15809
  • 财政年份:
    2023
  • 资助金额:
    $ 34.06万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Development of fetal stem cell therapy for cleft lip using sandwich-graft composed of bandage epithelial tissue(BET) and amniotic fluid spheroid
使用绷带上皮组织(BET)和羊水球体组成的三明治移植物开发胎儿干细胞治疗唇裂
  • 批准号:
    21K21032
  • 财政年份:
    2021
  • 资助金额:
    $ 34.06万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Investigation of the coagulopathy involving amniotic fluid embolism: Towards development of the specific earlier assessment
涉及羊水栓塞的凝血障碍的调查:制定具体的早期评估
  • 批准号:
    21K16811
  • 财政年份:
    2021
  • 资助金额:
    $ 34.06万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Automatic Segmentation of Amniotic Fluid using Deep Learning
使用深度学习自动分割羊水
  • 批准号:
    565347-2021
  • 财政年份:
    2021
  • 资助金额:
    $ 34.06万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
Verification of therapeutic effects by amniotic fluid stem cell sheet for rat myelomeningocele model.
羊水干细胞片对大鼠脊髓脊膜膨出模型治疗效果的验证。
  • 批准号:
    21K16599
  • 财政年份:
    2021
  • 资助金额:
    $ 34.06万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Extracellular vesicles derived from amniotic fluid stem cells normalize glomerular function during progressive kidney disease.
来自羊水干细胞的细胞外囊泡在进行性肾脏疾病期间使肾小球功能正常化。
  • 批准号:
    10348192
  • 财政年份:
    2020
  • 资助金额:
    $ 34.06万
  • 项目类别:
Extracellular vesicles derived from amniotic fluid stem cells normalize glomerular function during progressive kidney disease.
来自羊水干细胞的细胞外囊泡在进行性肾脏疾病期间使肾小球功能正常化。
  • 批准号:
    10549376
  • 财政年份:
    2020
  • 资助金额:
    $ 34.06万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了